Last reviewed · How we verify
Nalbuphine in superficial cervical plexus block
Nalbuphine in superficial cervical plexus block is a Small molecule drug developed by Kasr El Aini Hospital. It is currently FDA-approved. Also known as: Nalufin.
At a glance
| Generic name | Nalbuphine in superficial cervical plexus block |
|---|---|
| Also known as | Nalufin |
| Sponsor | Kasr El Aini Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Analgesic Efficacy of Perineural Nalbuphine as an Adjuvant to Bupivacaine in Ultrasound Guided Superficial Cervical Plexus Nerve Block for Thyroid Surgeries. A Double Blinded Randomized Controlled Trial. (PHASE2)
- Dexmedetomidine and Nalbuphine as Analgesic Adjuvants to Bupivacaine in Superficial Cervical Block. (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nalbuphine in superficial cervical plexus block CI brief — competitive landscape report
- Nalbuphine in superficial cervical plexus block updates RSS · CI watch RSS
- Kasr El Aini Hospital portfolio CI
Frequently asked questions about Nalbuphine in superficial cervical plexus block
What is Nalbuphine in superficial cervical plexus block?
Nalbuphine in superficial cervical plexus block is a Small molecule drug developed by Kasr El Aini Hospital.
Who makes Nalbuphine in superficial cervical plexus block?
Nalbuphine in superficial cervical plexus block is developed and marketed by Kasr El Aini Hospital (see full Kasr El Aini Hospital pipeline at /company/kasr-el-aini-hospital).
Is Nalbuphine in superficial cervical plexus block also known as anything else?
Nalbuphine in superficial cervical plexus block is also known as Nalufin.
What development phase is Nalbuphine in superficial cervical plexus block in?
Nalbuphine in superficial cervical plexus block is FDA-approved (marketed).
Related
- Manufacturer: Kasr El Aini Hospital — full pipeline
- Also known as: Nalufin
- Compare: Nalbuphine in superficial cervical plexus block vs similar drugs
- Pricing: Nalbuphine in superficial cervical plexus block cost, discount & access